Mingjiu Chen

453 total citations
26 papers, 331 citations indexed

About

Mingjiu Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mingjiu Chen has authored 26 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Mingjiu Chen's work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Mingjiu Chen is often cited by papers focused on RNA modifications and cancer (6 papers), MicroRNA in disease regulation (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Mingjiu Chen collaborates with scholars based in China, United States and Taiwan. Mingjiu Chen's co-authors include Chen Chen, Yunchang Yuan, Wen Hu, Jie Deng, Weilin Peng, Fenglei Yu, Zhenkun Xia, Wenliang Liu, Bangliang Yin and Muyun Peng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mingjiu Chen

23 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjiu Chen China 9 208 173 73 56 31 26 331
Jing Cui China 13 213 1.0× 152 0.9× 35 0.5× 88 1.6× 33 1.1× 19 328
Yanwei Ye China 10 181 0.9× 93 0.5× 45 0.6× 74 1.3× 29 0.9× 23 315
Shaoshui Chen China 9 169 0.8× 109 0.6× 70 1.0× 97 1.7× 19 0.6× 16 327
Shibo Yu China 10 175 0.8× 124 0.7× 112 1.5× 92 1.6× 25 0.8× 26 367
Dezhi Cheng China 12 237 1.1× 148 0.9× 84 1.2× 63 1.1× 27 0.9× 27 378
Danbi Seo South Korea 4 178 0.9× 123 0.7× 67 0.9× 56 1.0× 17 0.5× 6 328
Jiaxiang Wang China 10 176 0.8× 122 0.7× 50 0.7× 55 1.0× 22 0.7× 24 295
Weiqiang You China 9 212 1.0× 146 0.8× 55 0.8× 102 1.8× 30 1.0× 12 321
Haigang Geng China 7 140 0.7× 74 0.4× 75 1.0× 72 1.3× 32 1.0× 20 311

Countries citing papers authored by Mingjiu Chen

Since Specialization
Citations

This map shows the geographic impact of Mingjiu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjiu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjiu Chen more than expected).

Fields of papers citing papers by Mingjiu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjiu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjiu Chen. The network helps show where Mingjiu Chen may publish in the future.

Co-authorship network of co-authors of Mingjiu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjiu Chen. A scholar is included among the top collaborators of Mingjiu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjiu Chen. Mingjiu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hongyan, Jinyu Liu, Wenwen Dai, et al.. (2025). Siglec-15 antibody–GM-CSF chimera suppresses tumor progression via reprogramming tumor-associated macrophages. Journal for ImmunoTherapy of Cancer. 13(4). e010580–e010580.
2.
De-xing, Chen, Siyu Chen, Yuqing Lin, et al.. (2024). Variations in soil fungal communities: Comparative insights from coniferous and mixed broadleaf-conifer forests. Pedobiologia. 107. 151007–151007. 2 indexed citations
3.
Hu, Yerong, Yangzhao Zhou, Wenliang Liu, et al.. (2024). AXL and SHC1 confer crizotinib resistance in patient-derived xenograft model of ALK-driven lung cancer. iScience. 27(9). 110846–110846. 1 indexed citations
4.
Li, Hongyan, Xiaodong Liu, Jinyu Liu, et al.. (2024). Abstract 3135: BSI-730, a bispecific antibody targeting HER2 and PD-L1 for the development of a first-in-class bispecific ADC. Cancer Research. 84(6_Supplement). 3135–3135. 1 indexed citations
5.
Peng, Weilin, Long Wen, Rong Jiang, Jie Deng, & Mingjiu Chen. (2023). CHAC2 promotes lung adenocarcinoma by regulating ROS-mediated MAPK pathway activation. Journal of Cancer. 14(8). 1309–1320. 6 indexed citations
8.
Lin, Xinqing, Muyun Peng, Quanfang Chen, et al.. (2021). Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With EGFR Germline Mutations in a Large-Scale Retrospective Study. Frontiers in Oncology. 11. 774156–774156. 11 indexed citations
9.
Chen, Chen, Xiaojie Huang, Wei Yin, et al.. (2020). Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules. Clinical Epigenetics. 12(1). 39–39. 44 indexed citations
10.
Chen, Mingjiu, et al.. (2019). LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis. The International Journal of Biochemistry & Cell Biology. 113. 27–36. 67 indexed citations
11.
Guo, Renhua, Jun Zhao, Lingjun Zhu, et al.. (2019). EGFR extracellular domain mutation in patients with lung cancer.. Journal of Clinical Oncology. 37(15_suppl). e20532–e20532. 7 indexed citations
12.
Chen, Mingjiu, et al.. (2018). LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway. Anti-Cancer Drugs. 29(8). 767–773. 54 indexed citations
13.
Chen, Chen, et al.. (2018). Successful removal of giant mediastinal lipoma and liposarcoma involving both chest cavities. Medicine. 97(32). e11806–e11806. 8 indexed citations
14.
Chen, Mingjiu, et al.. (2018). miR‑126/VCAM‑1 regulation by naringin suppresses cell growth of human non‑small cell lung cancer. Oncology Letters. 16(4). 4754–4760. 33 indexed citations
15.
Chen, Jian & Mingjiu Chen. (2018). [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].. PubMed. 43(10). 1048–1053. 2 indexed citations
16.
Chen, Chen, et al.. (2015). Surgical management of a giant sternal chondromyxoid fibroma: a case report. Journal of Cardiothoracic Surgery. 10(1). 178–178. 6 indexed citations
17.
Gu, Jinming, Jinsong Yang, Qing Chang, et al.. (2014). Identification of Anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig™) Proteins with Unique Activities. PLoS ONE. 9(5). e97292–e97292. 14 indexed citations
18.
Liu, Haidan, Yunchang Yuan, Zhenkun Xia, et al.. (2014). Regulation of Mcl-1 by constitutive activation of NF-kappaB contributes to cell viability in human esophageal squamous cell carcinoma cells. BMC Cancer. 14(1). 98–98. 44 indexed citations
19.
Wu, Xianning, et al.. (2012). Pulmonary Artery Pseudoaneurysm Caused by a Rare Vascular Tumor: Epithelioid Hemangioendothelioma. The Thoracic and Cardiovascular Surgeon. 62(1). 92–94. 5 indexed citations
20.
Liao, Xiao‐Bo, et al.. (2004). [Expression of PTEN, p16, p21, and p53 proteins in lung cancer using tissue microarray and their clinical significance].. PubMed. 23(3). 334–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026